Testing a vaginal probiotic treatment for bacterial imbalance
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests whether introducing beneficial organisms into the vagina can help treat bacterial vaginosis (a common vaginal imbalance). You'll be part of the FRESH research program and receive either the treatment or a comparison option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18–25 years old and already enrolled in the FRESH study
- You have a Nugent score of 4 or higher (a test showing vaginal bacterial imbalance)
- You use an effective birth control method (pill, patch, injection, ring, implant, condom, diaphragm, or non-levonorgestrel IUD)
- You have not had recent vaginal infections (other than bacterial vaginosis) in the past 30 days
- You are not pregnant, breastfeeding, or trying to conceive within 24 weeks before the study
- You have not taken antibiotics or probiotics in the past 30 days (plain yogurt with live cultures is allowed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This trial tests if a probiotic called LRa05 can help treat bacterial vaginosis (an imbalance in vaginal bacteria) and support ovary health. It may be an option for premenopausal women with this condition.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.
Hear when a new Recurrent Bacterial Vaginosis (BV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.